Related Experiment Video
Updated: Mar 19, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
Tumor Suppressor HIPK2 Regulates Malignant Growth via Phosphorylation of Notch1
Eun-Jung Ann1, Mi-Yeon Kim2, Ji-Hye Yoon1
1Hormone Research Center, School of Biological Sciences and Technology, Chonnam National University, Gwangju, Republic of Korea.
Abstract:
The receptor Notch1 plays an important role in malignant progression of many cancers, but its regulation is not fully understood. In this study, we report that the kinase HIPK2 is responsible for facilitating the Fbw7-dependent proteasomal degradation of Notch1 by phosphorylating its intracellular domain (Notch1-IC) within the Cdc4 phosphodegron motif. Notch1-IC expression was higher in cancer cells than normal cells. Under genotoxic stress, Notch1-IC was phosphorylated constitutively by HIPK2 and was maintained at a low level through proteasomal degradation. HIPK2 phosphorylated the residue T2512 in Notch1-IC. Somatic mutations near this residue rendered Notch1-IC resistant to degradation, as induced either by HIPK2 overexpression or adriamycin treatment. In revealing an important mechanism of Notch1 stability, the results of this study could offer a therapeutic strategy to block Notch1-dependent progression in many types of cancer. Cancer Res; 76(16); 4728-40. ©2016 AACR.
Insights
The kinase HIPK2 targets Notch1 for degradation, reducing its levels in cancer cells. This discovery offers a potential strategy to inhibit Notch1-driven cancer progression.
Area of Science:
- Molecular Biology
- Cancer Biology
- Cell Signaling
Background:
- Notch1 receptor is crucial for cancer progression, but its regulatory mechanisms remain unclear.
- Understanding Notch1 regulation is vital for developing targeted cancer therapies.
Purpose of the Study:
- To elucidate the role of HIPK2 in regulating Notch1 stability.
- To identify the mechanism by which HIPK2 controls Notch1 degradation.
Main Methods:
- Investigated the interaction between HIPK2 and Notch1.
- Utilized cell-based assays to study Notch1 phosphorylation and degradation.
- Analyzed the effect of mutations on Notch1 stability under genotoxic stress.
Main Results:
- HIPK2 phosphorylates Notch1 intracellular domain (Notch1-IC) at T2512, targeting it for Fbw7-dependent proteasomal degradation.
- Notch1-IC expression is elevated in cancer cells and reduced by HIPK2-mediated degradation under genotoxic stress.
- Mutations near T2512 confer resistance to Notch1 degradation.
Conclusions:
- HIPK2 acts as a key regulator of Notch1 stability through phosphorylation-dependent degradation.
- This pathway represents a potential therapeutic target for cancers driven by Notch1.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
07:16Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Notch Signaling Pathway